Natures Sunshine Products Inc (NATR) stock
NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3058% below fair value
$10.32−0.01 (-0.10%)
Close on Nov 18, 2026Market cap $181.59MP/E 10.2Yield –
Natures Sunshine Products revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Natures Sunshine Products's revenue for the twelve months ending Jun 30, 2026 was $492.02M, up 6.8% year over year. For fiscal 2025 it was $480.14M, up 5.7% from the year before. Over ten years it grew 4.0% a year on average. The highest annual figure on record is $480.14M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $480.14M | +5.7% |
| FY2024 | Dec 31, 2024 | $454.36M | +2.0% |
| FY2023 | Dec 31, 2023 | $445.32M | +5.5% |
| FY2022 | Dec 31, 2022 | $421.91M | -5.0% |
| FY2021 | Dec 31, 2021 | $444.08M | +15.3% |
| FY2020 | Dec 31, 2020 | $385.21M | +6.3% |
| FY2019 | Dec 31, 2019 | $362.22M | -0.7% |
| FY2018 | Dec 31, 2018 | $364.81M | +6.7% |
| FY2017 | Dec 31, 2017 | $342.03M | +0.3% |
| FY2016 | Dec 31, 2016 | $341.16M | +5.1% |
| FY2015 | Dec 31, 2015 | $324.71M | -11.4% |
| FY2014 | Dec 31, 2014 | $366.37M | -0.9% |
| FY2013 | Dec 31, 2013 | $369.83M | +2.5% |
| FY2012 | Dec 31, 2012 | $360.83M | -1.9% |
| FY2011 | Dec 31, 2011 | $367.81M | +5.1% |
| FY2010 | Dec 31, 2010 | $349.92M | +2.3% |
| FY2009 | Dec 31, 2009 | $342.11M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $116.99M | +1.9% |
| Q1 FY2026 | Mar 31, 2026 | $122.89M | +8.5% |
| Q4 FY2025 | Dec 31, 2025 | $123.81M | +4.7% |
| Q3 FY2025 | Sep 30, 2025 | $128.34M | +12.0% |
| Q2 FY2025 | Jun 30, 2025 | $114.75M | +3.8% |
| Q1 FY2025 | Mar 31, 2025 | $113.25M | +2.0% |
| Q4 FY2024 | Dec 31, 2024 | $118.21M | +8.5% |
| Q3 FY2024 | Sep 30, 2024 | $114.62M | +3.1% |
| Q2 FY2024 | Jun 30, 2024 | $110.55M | -5.1% |
| Q1 FY2024 | Mar 31, 2024 | $110.99M | +2.2% |
| Q4 FY2023 | Dec 31, 2023 | $108.94M | +6.0% |
| Q3 FY2023 | Sep 30, 2023 | $111.20M | +6.4% |
| Q2 FY2023 | Jun 30, 2023 | $116.55M | +11.9% |
| Q1 FY2023 | Mar 31, 2023 | $108.63M | -1.7% |
| Q4 FY2022 | Dec 31, 2022 | $102.75M | -12.9% |
| Q3 FY2022 | Sep 30, 2022 | $104.51M | -8.9% |
| Q2 FY2022 | Jun 30, 2022 | $104.16M | -4.4% |
| Q1 FY2022 | Mar 31, 2022 | $110.49M | +7.9% |
| Q4 FY2021 | Dec 31, 2021 | $117.94M | +15.9% |
| Q3 FY2021 | Sep 30, 2021 | $114.75M | +14.5% |
| Q2 FY2021 | Jun 30, 2021 | $108.98M | +24.9% |
| Q1 FY2021 | Mar 31, 2021 | $102.42M | +6.8% |
| Q4 FY2020 | Dec 31, 2020 | $101.74M | +11.0% |
| Q3 FY2020 | Sep 30, 2020 | $100.25M | +13.2% |
| Q2 FY2020 | Jun 30, 2020 | $87.29M | -3.8% |
| Q1 FY2020 | Mar 31, 2020 | $95.93M | +5.1% |
| Q4 FY2019 | Dec 31, 2019 | $91.70M | -5.8% |
| Q3 FY2019 | Sep 30, 2019 | $88.52M | -0.3% |
| Q2 FY2019 | Jun 30, 2019 | $90.72M | -0.6% |
| Q1 FY2019 | Mar 31, 2019 | $91.27M | +4.5% |
| Q4 FY2018 | Dec 31, 2018 | $97.37M | +10.3% |
| Q3 FY2018 | Sep 30, 2018 | $88.83M | -0.5% |
| Q2 FY2018 | Jun 30, 2018 | $91.27M | +12.2% |
| Q1 FY2018 | Mar 31, 2018 | $87.34M | +5.1% |
| Q4 FY2017 | Dec 31, 2017 | $88.29M | +5.2% |
| Q3 FY2017 | Sep 30, 2017 | $89.30M | +4.5% |
| Q2 FY2017 | Jun 30, 2017 | $81.34M | – |
| Q1 FY2017 | Mar 31, 2017 | $83.10M | – |
| Q4 FY2016 | Dec 31, 2016 | $83.95M | – |
| Q3 FY2016 | Sep 30, 2016 | $85.44M | – |
See a number that looks wrong?